Rice Steven J. 4
4 · Vir Biotechnology, Inc. · Filed Aug 24, 2021
Insider Transaction Report
Form 4
Rice Steven J.
Chief Administrative Officer
Transactions
- Sale
Common Stock
2021-08-23$50.00/sh−10,000$500,000→ 20,000 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-08-23−10,000→ 434,441 totalExercise: $12.76Exp: 2029-12-10→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2021-08-23$12.76/sh+10,000$127,600→ 30,000 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021.
- [F2]1/4 of the shares subject to the stock option vest and become exercisable on September 15, 2020, and the remainder vest in 36 equal monthly installments thereafter.